19-3633453-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012398.3(PIP5K1C):āc.1988A>Gā(p.Asp663Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000876 in 1,495,936 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000072 ( 0 hom., cov: 33)
Exomes š: 0.000089 ( 1 hom. )
Consequence
PIP5K1C
NM_012398.3 missense
NM_012398.3 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 4.79
Genes affected
PIP5K1C (HGNC:8996): (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma) This locus encodes a type I phosphatidylinositol 4-phosphate 5-kinase. The encoded protein catalyzes phosphorylation of phosphatidylinositol 4-phosphate, producing phosphatidylinositol 4,5-bisphosphate. This enzyme is found at synapses and has been found to play roles in endocytosis and cell migration. Mutations at this locus have been associated with lethal congenital contractural syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09634444).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIP5K1C | NM_012398.3 | c.1988A>G | p.Asp663Gly | missense_variant | 17/18 | ENST00000335312.8 | NP_036530.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIP5K1C | ENST00000335312.8 | c.1988A>G | p.Asp663Gly | missense_variant | 17/18 | 1 | NM_012398.3 | ENSP00000335333 | P3 | |
PIP5K1C | ENST00000679885.1 | c.2066A>G | p.Asp689Gly | missense_variant | 18/19 | ENSP00000504894 | A1 | |||
PIP5K1C | ENST00000539785.5 | c.1921-284A>G | intron_variant | 2 | ENSP00000445992 | A1 | ||||
PIP5K1C | ENST00000679828.1 | c.*1527A>G | 3_prime_UTR_variant, NMD_transcript_variant | 18/19 | ENSP00000506175 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 151888Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
11
AN:
151888
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000133 AC: 22AN: 165722Hom.: 0 AF XY: 0.000191 AC XY: 17AN XY: 89204
GnomAD3 exomes
AF:
AC:
22
AN:
165722
Hom.:
AF XY:
AC XY:
17
AN XY:
89204
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000893 AC: 120AN: 1343930Hom.: 1 Cov.: 31 AF XY: 0.000131 AC XY: 86AN XY: 657506
GnomAD4 exome
AF:
AC:
120
AN:
1343930
Hom.:
Cov.:
31
AF XY:
AC XY:
86
AN XY:
657506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000724 AC: 11AN: 152006Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74326
GnomAD4 genome
AF:
AC:
11
AN:
152006
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
12
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.1988A>G (p.D663G) alteration is located in exon 17 (coding exon 17) of the PIP5K1C gene. This alteration results from a A to G substitution at nucleotide position 1988, causing the aspartic acid (D) at amino acid position 663 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of glycosylation at S662 (P = 0.1112);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at